Kamunting Street Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,736
Closed -$249K 54
2023
Q1
$249K Buy
+7,736
New +$249K 0.32% 21